Scientists Are "Reolysin" The Power Of Live Biologics To Fight Cancer In Two Recent S
A novel class of cancer therapies called live biologics is offering new hope for patients affected by hard-to-treat cancers, according to two different studies testing the therapies in patients with sarcomas and head and neck cancers. Traditional cancer treatments such as chemotherapy and radiotherapy come with a serious disadvantage: they cannot distinguish cancer cells from normal cells. Since normal cells can be stunted by chemotherapy and destroyed by radiation along with abnormal cells, patients may experience serious health issues during a course of extended treatment...
More...
A novel class of cancer therapies called live biologics is offering new hope for patients affected by hard-to-treat cancers, according to two different studies testing the therapies in patients with sarcomas and head and neck cancers. Traditional cancer treatments such as chemotherapy and radiotherapy come with a serious disadvantage: they cannot distinguish cancer cells from normal cells. Since normal cells can be stunted by chemotherapy and destroyed by radiation along with abnormal cells, patients may experience serious health issues during a course of extended treatment...
More...